Home/Filings/4/0001140361-25-041393
4//SEC Filing

Wilson Martin 4

Accession 0001140361-25-041393

CIK 0001281895other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 4:25 PM ET

Size

4.7 KB

Accession

0001140361-25-041393

Insider Transaction Report

Form 4
Period: 2025-11-03
Wilson Martin
General Counsel
Transactions
  • Award

    Common Stock

    2025-11-03+100,000385,462 total
Footnotes (2)
  • [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  • [F2]Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026.

Issuer

ROCKET PHARMACEUTICALS, INC.

CIK 0001281895

Entity typeother

Related Parties

1
  • filerCIK 0001704342

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:25 PM ET
Size
4.7 KB